Cetuximab-beta drug page Clinical trials

Trials with Cetuximab-beta

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
46Planned patients

Showing 1–1 of 1

Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC
Recruiting Phase 2 46 patients NCT07724223

This study aims to evaluate the effectiveness and safety of combining fruquintinib (an oral anti-angiogenesis drug) with cetuximab-beta (an anti-EGFR antibody) in patients with RAS wild-type metastatic colorectal cancer who have already fa…

China Jan 2026 – Jan 2029 Interventional
Combined with: Fruquintinib

Where the recruiting trials are